In an era where autoimmune and inflammatory eye disorders are gaining recognition for their profound impact on vision and quality of life, the scleritis market is experiencing a steady resurgence driven by diagnostic advancements and targeted therapies. The global scleritis market size was valued at USD 3.39 billion in 2024 and is expected to reach USD 5.28 billion by...